Literature DB >> 19878310

Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer.

Alison M Michie1, Alison M McCaig, Rinako Nakagawa, Milica Vukovic.   

Abstract

Death-associated protein kinase (DAPK) is a pro-apoptotic serine/threonine protein kinase that is dysregulated in a wide variety of cancers. The mechanism by which this occurs has largely been attributed to promoter hypermethylation, which results in gene silencing. However, recent studies indicate that DAPK expression can be detected in some cancers, but its function is still repressed, suggesting that DAPK activity can be subverted at a post-translational level in cancer cells. This review will focus on recent data describing potential mechanisms that may alter the expression, regulation or function of DAPK.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878310     DOI: 10.1111/j.1742-4658.2009.07414.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  38 in total

1.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function.

Authors:  Tae Ho Lee; Chun-Hau Chen; Futoshi Suizu; Pengyu Huang; Cordelia Schiene-Fischer; Sebastian Daum; Yan Jessie Zhang; Alison Goate; Ruey-Hwa Chen; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Mol Cell       Date:  2011-04-14       Impact factor: 17.970

2.  Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.

Authors:  Fan-Fan Li; Yang Yang; Xiao-Lei Wang; Yan-Yan Hong; Nian-Fei Wang; Zhen-Dong Chen
Journal:  Tumour Biol       Date:  2014-06

3.  DNA Methylation and Flavonoids in Genitourinary Cancers.

Authors:  Neelam Mukherjee; Addanki P Kumar; Rita Ghosh
Journal:  Curr Pharmacol Rep       Date:  2015-04-01

Review 4.  Epigenetics and cervical cancer: from pathogenesis to therapy.

Authors:  Jinchuan Fang; Hai Zhang; Sufang Jin
Journal:  Tumour Biol       Date:  2014-02-20

5.  Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.

Authors:  Pingping Mao; Mary P Hever; Lynne M Niemaszyk; Jessica M Haghkerdar; Esty G Yanco; Damayanti Desai; Maroun J Beyrouthy; Joanna S Kerley-Hamilton; Sarah J Freemantle; Michael J Spinella
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

Review 6.  Proteomics analysis of bodily fluids in pancreatic cancer.

Authors:  Sheng Pan; Teresa A Brentnall; Ru Chen
Journal:  Proteomics       Date:  2015-04-27       Impact factor: 3.984

7.  DNA methylation in promoter region as biomarkers in prostate cancer.

Authors:  Mihi Yang; Jong Y Park
Journal:  Methods Mol Biol       Date:  2012

8.  Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.

Authors:  Chiaki Banzai; Koji Nishino; Jinhua Quan; Kosuke Yoshihara; Masayuki Sekine; Tetsuro Yahata; Kenichi Tanaka
Journal:  Int J Clin Oncol       Date:  2013-03-14       Impact factor: 3.402

9.  Methylation of DAPK and THBS1 genes in esophageal gastric-type columnar metaplasia.

Authors:  Roberto Herrera-Goepfert; Luis F Oñate-Ocaña; José Luis Mosqueda-Vargas; Luis A Herrera; Clementina Castro; Julia Mendoza; Rodrigo González-Barrios
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

10.  Methylation-mediated molecular dysregulation in clinical oral malignancy.

Authors:  Rebecca Towle; Cathie Garnis
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.